Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLuzerner Kantonsspital

About this trial

This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.

Eligibility criteria

Qualifiers

ICD-10 Diagnosis of stroke, TBI or MS

Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation

Age 18 years old or older

Understanding the German language

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Intervention Hypnosis

Treatment groups

48 Participants
are divided into 2 treatment groups

Sponsors and collaborators